Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Venom toxin proteins comprise a highly diverse group of bioactive proteins found in animal venoms, primarily in snakes, but also in spiders, scorpions, and cone snails. These toxins are classified into families such as phospholipase A2, metalloproteases, serine proteases, three-finger toxins, and C-type lectins, among many others[2][4]. They exert their effects via enzymatic activity, modulation of blood coagulation, neurotoxic and cytotoxic actions, and interference with physiological signaling in victims[1][3]. These proteins are studied for their potential as pharmacological tools, drug leads, and as targets for antivenom development, but "Venom toxin proteins" is too broad to be used as a specific therapeutic target or receptor. Each protein family and even individual toxins within venom can have unique structure, activity, and pharmacological significance[2][3][5][7]. To obtain structured, actionable information, future queries should specify an individual toxin or protein family (e.g., "Phospholipase A2 from Bothrops snake venom" or "Three-finger toxin from cobra venom"), rather than the generic category "Venom toxin proteins".
Enzymatic cleavage of physiological substrates (e.g., proteases, phospholipases)[1][3] Inhibition or activation of ion channels (e.g., dendrotoxin blocks Kv1 potassium channels)[5][6] Binding to receptor proteins and interference with signaling pathways Disruption of cell membranes (cytolytic action)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venom toxin protein.